Learn More
Medchemexpress LLC Triflusal | 322-79-2 | 99.6% | 100 MG

Supplier: Medchemexpress LLC HYB0531100MG
Triflusal is an orally bioavailable, blood-brain barrier-permeable dual Cyclooxygenase-1 (COX-1)/cAMP phosphodiesterase inhibitor. It has shown promise in alleviating cerebral ischemic injury in rats and ameliorating pathological lesions and related gene expression in transgenic Alzheimer's disease models. It is intended for research on thromboembolic/ischemic cardiovascular and cerebrovascular diseases, and Alzheimer's disease.
- Inhibits platelet aggregation.
- Inhibits NF-κB activation.
- Inhibits iNOS activity.
- Inhibits prostaglandin synthesis in ischaemic tissue.
- Stimulates neutrophil nitric oxide production.
- Stimulates eNOS protein expression.
- Stimulates cNOS activity.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.